1. Home
  2. APPF vs RGEN Comparison

APPF vs RGEN Comparison

Compare APPF & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AppFolio Inc.

APPF

AppFolio Inc.

HOLD

Current Price

$234.42

Market Cap

8.3B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.51

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPF
RGEN
Founded
2006
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
APPF
RGEN
Price
$234.42
$162.51
Analyst Decision
Strong Buy
Buy
Analyst Count
8
10
Target Price
$310.75
$174.90
AVG Volume (30 Days)
212.5K
701.7K
Earning Date
01-29-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
58.16
N/A
EPS
5.58
0.03
Revenue
$906,294,000.00
$707,890,000.00
Revenue This Year
$21.87
$17.84
Revenue Next Year
$18.51
$12.57
P/E Ratio
$41.84
$5,259.20
Revenue Growth
18.88
11.74
52 Week Low
$190.24
$102.97
52 Week High
$326.04
$182.52

Technical Indicators

Market Signals
Indicator
APPF
RGEN
Relative Strength Index (RSI) 50.41 54.15
Support Level $222.23 $156.01
Resistance Level $239.00 $165.02
Average True Range (ATR) 6.49 4.65
MACD 1.05 -1.07
Stochastic Oscillator 67.65 43.33

Price Performance

Historical Comparison
APPF
RGEN

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: